Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol

Am J Emerg Med. 2017 Mar;35(3):519.e1-519.e4. doi: 10.1016/j.ajem.2016.09.040. Epub 2016 Sep 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / therapeutic use
  • Amphetamine-Related Disorders / complications
  • Anti-Anxiety Agents / administration & dosage
  • Anti-Anxiety Agents / adverse effects
  • Anti-Anxiety Agents / therapeutic use
  • Anxiety / chemically induced
  • Anxiety / drug therapy
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular System / drug effects*
  • Central Nervous System Stimulants / pharmacology
  • Central Nervous System Stimulants / toxicity
  • Chest Pain / chemically induced
  • Chest Pain / diagnosis
  • Cocaine / toxicity*
  • Cocaine-Related Disorders / complications
  • Drug Interactions
  • Electrocardiography
  • Humans
  • Hyperhidrosis / chemically induced
  • Hyperhidrosis / drug therapy
  • Labetalol / administration & dosage*
  • Labetalol / therapeutic use
  • Lorazepam / administration & dosage*
  • Lorazepam / adverse effects
  • Lorazepam / therapeutic use
  • Male
  • Methamphetamine / pharmacology
  • Methamphetamine / toxicity*
  • Sodium Chloride / administration & dosage
  • Sodium Chloride / therapeutic use
  • Tachycardia / chemically induced
  • Tachycardia / diagnosis
  • Young Adult

Substances

  • Adrenergic beta-Antagonists
  • Anti-Anxiety Agents
  • Central Nervous System Stimulants
  • Methamphetamine
  • Sodium Chloride
  • Cocaine
  • Lorazepam
  • Labetalol